RSL1D1 and colorectal carcinoma: Notably, the Kaplan–Meier survival test showed that CRC patients with high RSL1D1 expression had poorer long-term survival (overall survival: LogRank=27.28, P < 0.001; progression-free survival: LogRank=12.78, P = 0.0003, Fig. 1E).